After binding to ACE2 and entry of the SARS-CoV-2 to the target cells, shedding of host ACE2 receptors occurs that may disrupt RAS tissue homeostasis leading to important implications for COVID-19 severity [10, 11, 12]. The gene discussed is ACE2; the disease is COVID-19.